SWK HOLDINGS CORPORATION (OTCMKTS:SWKH) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07 Submission of Matters to a Vote of Security Holders
SWK Holdings Corporation (the “Company”) held its 2018 annual meeting of stockholders on May 21, 2018. At the meeting, the Company’s stockholders elected Michael Weinberg, D. Blair Baker, Christopher W. Haga, and Edward B. Stead, to serve as directors for a term expiring in 2019. Additionally, stockholders voted to ratify the selection of BPM, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018. Stockholders also voted affirmatively on an advisory basis to approve the compensation to certain executives.
1.Election of Directors
| Nominee | For | Withhold Authority | Broker Non-Votes |
| Michael Weinberg | 9,657,315 | 162,950 | 942,022 |
| D. Blair Baker | 9,659,468 | 160,797 | 942,022 |
| Christopher W. Haga | 9,658,386 | 161,879 | 942,022 |
| Edward B. Stead | 9,659,417 | 160,848 | 942,202 |
2.Ratification of Independent Registered Public Accounting Firm
| For | Against | Abstain | Broker Non-Votes |
| 10,700,541 | 29,755 | 31,991 |
3.Executive Compensation
| For | Against | Abstain | Broker Non-Votes |
| 9,783,680 | 2,977 | 33,608 | 942,202 |
About SWK HOLDINGS CORPORATION (OTCMKTS:SWKH)
SWK Holdings Corporation is a healthcare capital provider. The Company offers financing solutions to a range of life science companies, institutions and inventors. The Company’s focus is on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. The Company, through its subsidiary SWK Advisors LLC, provides non-discretionary investment advisory services to institutional clients in separately managed accounts to similarly invest in life science finance. It focuses to fund transactions through its own working capital, as well as by building its asset management business by raising additional third party capital to be invested alongside its capital. The Company evaluates and invests in a range of healthcare related companies and products.